Goldman Sachs Group Inc Neogenomics Inc Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,716,720 shares of NEO stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,716,720

Previous 1,716,720 -0.0%

Holding current value

$12 Million

Previous $16.3 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$9.09 - $18.61 $5.22 Million - $10.7 Million	-574,287 Reduced 25.07%	1,716,720 $16.3 Million
Q4 2024 Feb 11, 2025	SELL	$13.0 - $18.43 $2.53 Million - $3.59 Million	-194,625 Reduced 7.83%	2,291,007 $37.8 Million
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $5.28 Million - $6.99 Million	394,355 Added 18.86%	2,485,632 $36.7 Million
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $2.94 Million - $3.57 Million	-226,181 Reduced 9.76%	2,091,277 $29 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $426,200 - $508,955	30,313 Added 1.33%	2,317,458 $36.4 Million
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $2.1 Million - $3.73 Million	-179,991 Reduced 7.3%	2,287,145 $37 Million
Q3 2023 May 14, 2024	BUY	$12.15 - $17.85 $2.19 Million - $3.21 Million	179,991 Added 7.87%	2,467,136 $30.3 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $650,535 - $955,724	-53,542 Reduced 2.12%	2,467,136 $30.3 Million
Q2 2023 May 14, 2024	BUY	$14.1 - $19.83 $781,154 - $1.1 Million	55,401 Added 2.25%	2,520,678 $40.5 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $781,154 - $1.1 Million	55,401 Added 2.25%	2,520,678 $40.5 Million
Q1 2023 May 14, 2024	SELL	$9.09 - $19.45 $2.84 Million - $6.08 Million	-312,721 Reduced 11.26%	2,465,277 $42.9 Million
Q1 2023 May 11, 2023	SELL	$9.09 - $19.45 $2.84 Million - $6.08 Million	-312,721 Reduced 11.26%	2,465,277 $42.9 Million
Q4 2022 May 14, 2024	BUY	$6.45 - $12.07 $826,128 - $1.55 Million	128,082 Added 4.83%	2,777,998 $25.7 Million
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $826,128 - $1.55 Million	128,082 Added 4.83%	2,777,998 $25.7 Million
Q3 2022 May 14, 2024	SELL	$7.86 - $12.91 $6.02 Million - $9.88 Million	-765,479 Reduced 22.41%	2,649,916 $22.8 Million
Q3 2022 Nov 10, 2022	SELL	$7.86 - $12.91 $6.02 Million - $9.88 Million	-765,479 Reduced 22.41%	2,649,916 $22.8 Million
Q2 2022 May 14, 2024	BUY	$7.06 - $13.97 $7.97 Million - $15.8 Million	1,128,250 Added 49.33%	3,415,395 $27.8 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $21 Million - $41.5 Million	2,973,739 Added 673.32%	3,415,395 $27.8 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $804,342 - $2.34 Million	-66,201 Reduced 13.04%	441,656 $5.37 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $8.21 Million - $13.1 Million	269,139 Added 112.74%	507,857 $17.3 Million
Q3 2021 Nov 10, 2021	BUY	$41.66 - $52.52 $9.94 Million - $12.5 Million	238,718 New	238,718 $11.5 Million

Others Institutions Holding NEO

# of Institutions

288

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $881M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Neogenomics Inc Transaction History